Home›Search›Oncogenesis

Oncogenesis

Springer Nature · United Kingdom · Est. 1985

ISSN2157-9024eISSN2157-9024

SJR Q1✓ WOS SCIE✓ Scopus / SJR✓ DOAJ✓ Open Access

100

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (4 more)+22

Total100

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

170

days submission → published

measured · last 20 articles · accept 156d

weeks to publish · journal-reported

Slow · vs ~15 wk median

SJR Rank

Top 25% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei

2.081

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

1.233

Total Worksi

990

Total Citationsi

44,004

2yr Mean Citednessi

3.69

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope

Oncogenesis is a peer-reviewed open access online journal that publishes articles exploring mechanistic insight and molecular basis of cancer and related phenomena. It seeks to promote diverse and integrated areas of molecular biology, cell biology, oncology, and genetics. Oncogenesis seeks to encompass the breadth of the molecular biology of malignant change, and topics of particular interest include: Apoptosis Cancer metabolism Cell cycle and growth regulation Cellular oncogenes Cellular transformation and immortalization DNA damage and repair Mode of action of cancer therapeutics Molecular oncology Novel targeted therapies Senescence Tumour suppression Virus-induced oncogenesis

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published1985

FrequencyMonthly

StatusActive (last: 2026)

Total Publications990

Publisher OrgSpringer Nature

OA Since2011

Visit Journal Website

Submission Info

APC Cost$4,390Above median

Peer ReviewSingle-blind

Review Time~26 weeks

Acceptance Rate—

OA LicenseCC BY, CC BY-NC-ND

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

CLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

11/12 · 92%

✅

Do you know the journal / publisher?

Springer Nature

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2157-9024 / 2157-9024

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ, PubMed

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

✅

APC fees clearly disclosed?

$4,390

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

CLOCKSS

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

3.3k

2019

105

4.3k

2020

2021

2022

951

2023

367

2024

140

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Cancer ResearchQ1

Molecular BiologyQ1

Subject Classification

Web of Science Categories

Oncology

Scopus Categories

Cancer ResearchMolecular Biology

Research Topics (OpenAlex)

Cancer, Hypoxia, and MetabolismEpigenetics and DNA MethylationRNA modifications and cancerUbiquitin and proteasome pathwaysCancer Cells and MetastasisCancer-related Molecular PathwaysCancer-related molecular mechanisms researchCancer-related gene regulationMicroRNA in disease regulationWnt/β-catenin signaling in development and cancer

Frequently asked questions about Oncogenesis

Is Oncogenesis a predatory journal?

PubScope has no integrity flags on record for Oncogenesis: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 100/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Oncogenesis?

Oncogenesis is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 3.69.

Is Oncogenesis indexed in Scopus and Web of Science?

Oncogenesis is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Oncogenesis?

How much does it cost to publish in Oncogenesis?

Oncogenesis charges an article processing charge (APC) of about $4,390 for open-access publication.